InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-08-03 00:00:00 ET · period of report 2023-08-01 · accession 0001477449-23-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-03 2023-08-01 TDOC Waters Michael Willem COO M - OptEx — +45.3K 45.3K New —
D 2023-08-03 2023-08-02 TDOC Waters Michael Willem COO S - Sale+OE $27.03 -19.3K 25.9K -43% -$522.8K
D 2023-08-03 2023-08-01 TDOC Waters Michael Willem COO M - OptEx $0.00 -45.3K 90.6K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-01 M A 45,277 — 45,277 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2023-08-02 S D 19,340 $27.03 25,937 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2023-08-01 M D 45,277 $0.00 90,556 D — · — to — 45,277 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.